Skip to content
Disclosery

Privium Fund Management B.V.

Follow

13F filer, CIK 1795097, AMSTERDAM, Netherlands

Privium Fund Management B.V. reported $556,263,960 across 59 holdings for the quarter ended 2025-09-30, in a 13F-HR filed 2025-11-04. Its ten largest share positions make up 74.81% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001754960-25-000748

Period
2025-09-30
Reported value
$556M
Holdings
59
Top 10 weight
74.81%
New
8
Sold out
4

Largest buys vs the previous quarter

SecurityShares changeApprox. value
AMDnew+60,000$9.71M
LMNDnew+145,000$7.76M
IRENnew+130,000$6.1M
ASTSnew+110,000$5.4M
BIIBadded+31,425$4.4M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
PLTRreduced-150,000-$27.4M
SPOTreduced-19,000-$13.3M
SEreduced-50,000-$8.94M
ARWRreduced-138,263-$4.77M
QUREreduced-61,486-$3.59M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2025

Share positions as resolved from 13F-HR 0001754960-25-000748, largest first. % of portfolio is the value over $556,263,960, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
TSLATESLA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 216,000 shares; 2024Q4: 220,000 shares; 2025Q1: 220,000 shares; 2025Q2: 242,000 shares; 2025Q3: 244,000 shares 244,000$109M19.51%+2,000Timeline
SPOTSPOTIFY TECHNOLOGY S AQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 149,000 shares; 2024Q4: 145,000 shares; 2025Q1: 145,000 shares; 2025Q2: 114,000 shares; 2025Q3: 95,000 shares 95,000$66.3M11.92%-19,000Timeline
SHOPSHOPIFY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 415,000 shares; 2024Q4: 415,000 shares; 2025Q1: 415,000 shares; 2025Q2: 430,000 shares; 2025Q3: 415,000 shares 415,000$61.7M11.09%-15,000Timeline
PLTRPALANTIR TECHNOLOGIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 475,000 shares; 2024Q4: 370,000 shares; 2025Q1: 360,000 shares; 2025Q2: 350,000 shares; 2025Q3: 200,000 shares 200,000$36.5M6.56%-150,000Timeline
AMZNAMAZON COM INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 141,000 shares; 2024Q4: 141,000 shares; 2025Q1: 141,000 shares; 2025Q2: 149,000 shares; 2025Q3: 149,000 shares 149,000$32.7M5.88%0Timeline
SESEA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 210,000 shares; 2024Q4: 210,000 shares; 2025Q1: 210,000 shares; 2025Q2: 210,000 shares; 2025Q3: 160,000 shares 160,000$28.6M5.14%-50,000Timeline
COINCOINBASE GLOBAL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 70,000 shares; 2025Q3: 79,000 shares 79,000$26.7M4.79%+9,000Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 744,916 shares; 2024Q4: 742,162 shares; 2025Q1: 579,139 shares; 2025Q2: 447,486 shares; 2025Q3: 386,000 shares 386,000$22.5M4.05%-61,486Timeline
ARWRARROWHEAD PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 333,356 shares; 2024Q4: 380,586 shares; 2025Q1: 629,214 shares; 2025Q2: 612,214 shares; 2025Q3: 473,951 shares 473,951$16.3M2.94%-138,263Timeline
IONSIONIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 250,744 shares; 2024Q4: 266,794 shares; 2025Q1: 267,594 shares; 2025Q2: 267,594 shares; 2025Q3: 248,894 shares 248,894$16.3M2.93%-18,700Timeline
NVDANVIDIA CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 73,000 shares; 2024Q4: 73,000 shares; 2025Q1: 73,000 shares; 2025Q2: 81,000 shares; 2025Q3: 81,000 shares 81,000$15.1M2.72%0Timeline
PRQRPROQR THRAPEUTICS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 5,632,388 shares; 2024Q4: 4,985,633 shares; 2025Q1: 4,985,633 shares; 2025Q2: 4,997,562 shares; 2025Q3: 4,998,287 shares 4,998,287$10.6M1.91%+725Timeline
AMDADVANCED MICRO DEVICES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 44,000 shares; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 60,000 shares 60,000$9.71M1.75%newTimeline
RAREULTRAGENYX PHARMACEUTICAL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 242,512 shares; 2024Q4: 258,380 shares; 2025Q1: 249,804 shares; 2025Q2: 253,304 shares; 2025Q3: 289,804 shares 289,804$8.72M1.57%+36,500Timeline
LMNDLEMONADE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 145,000 shares 145,000$7.76M1.4%newTimeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 20,500 shares; 2025Q3: 51,925 shares 51,925$7.27M1.31%+31,425Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 80,232 shares; 2024Q4: 62,232 shares; 2025Q1: 52,732 shares; 2025Q2: 52,732 shares; 2025Q3: 52,732 shares 52,732$6.4M1.15%0Timeline
IRENIREN LIMITEDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 130,000 shares 130,000$6.1M1.1%newTimeline
ARQTARCUTIS BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 325,709 shares; 2025Q1: 325,709 shares; 2025Q2: 344,472 shares; 2025Q3: 305,972 shares 305,972$5.77M1.04%-38,500Timeline
MRKMERCK & CO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 60,111 shares; 2024Q4: 72,611 shares; 2025Q1: 41,093 shares; 2025Q2: 59,093 shares; 2025Q3: 64,393 shares 64,393$5.4M0.97%+5,300Timeline
ASTSAST SPACEMOBILE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 821,267 shares; 2024Q4: 111,500 shares; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 110,000 shares 110,000$5.4M0.97%newTimeline
ZLABZAI LAB LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 215,624 shares; 2024Q4: 185,062 shares; 2025Q1: 132,189 shares; 2025Q2: 132,189 shares; 2025Q3: 132,189 shares 132,189$4.48M0.81%0Timeline
URGNUROGEN PHARMA LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 27,691 shares; 2025Q1: 107,622 shares; 2025Q2: 107,622 shares; 2025Q3: 196,622 shares 196,622$3.92M0.71%+89,000Timeline
VRTXVERTEX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 8,300 shares; 2025Q2: 8,300 shares; 2025Q3: 8,300 shares 8,300$3.25M0.58%0Timeline
CRSPCRISPR THERAPEUTICS AGQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 30,347 shares; 2024Q4: 34,997 shares; 2025Q1: 60,097 shares; 2025Q2: 44,700 shares; 2025Q3: 40,000 shares 40,000$2.59M0.47%-4,700Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 30,412 shares 30,412$2.58M0.46%newTimeline
RNAMAVIDITY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 25,600 shares; 2024Q4: 31,900 shares; 2025Q1: 34,500 shares; 2025Q2: 46,000 shares; 2025Q3: 53,000 shares 53,000$2.31M0.42%+7,000Timeline
HIMSHIMS & HERS HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 22,000 shares; 2025Q3: 40,000 shares 40,000$2.27M0.41%+18,000Timeline
KRYSKRYSTAL BIOTECH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 6,350 shares; 2024Q4: 9,250 shares; 2025Q1: 7,510 shares; 2025Q2: 9,320 shares; 2025Q3: 12,170 shares 12,170$2.15M0.39%+2,850Timeline
ABEVAMBEV SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 622,314 shares; 2024Q4: 652,357 shares; 2025Q1: 804,206 shares; 2025Q2: 795,786 shares; 2025Q3: 897,134 shares 897,134$2M0.36%+101,348Timeline
ROIVROIVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 484,500 shares; 2024Q4: 215,506 shares; 2025Q1: 126,923 shares; 2025Q2: 126,923 shares; 2025Q3: 126,923 shares 126,923$1.92M0.35%0Timeline
BNTXBIONTECH SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 10,987 shares; 2025Q3: 19,000 shares 19,000$1.87M0.34%+8,013Timeline
FDMT4D MOLECULAR THERAPEUTICS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 98,500 shares; 2024Q4: 121,000 shares; 2025Q1: 131,000 shares; 2025Q2: 197,458 shares; 2025Q3: 197,458 shares 197,458$1.72M0.31%0Timeline
ACADACADIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 148,400 shares; 2024Q4: 148,400 shares; 2025Q1: 148,400 shares; 2025Q2: 148,400 shares; 2025Q3: 70,400 shares 70,400$1.5M0.27%-78,000Timeline
BEAMBEAM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 61,000 shares 61,000$1.48M0.27%newTimeline
RCKTROCKET PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 294,800 shares; 2024Q4: 397,650 shares; 2025Q1: 432,760 shares; 2025Q2: 432,760 shares; 2025Q3: 432,760 shares 432,760$1.41M0.25%0Timeline
MGTXMEIRAGTX HLDGS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 213,960 shares; 2024Q4: 225,078 shares; 2025Q1: 117,000 shares; 2025Q2: 163,000 shares; 2025Q3: 163,000 shares 163,000$1.34M0.24%0Timeline
LXEOLEXEO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: 138,115 shares; 2025Q1: 160,198 shares; 2025Q2: 178,356 shares; 2025Q3: 192,356 shares 192,356$1.28M0.23%+14,000Timeline
WVEWAVE LIFE SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 48,834 shares; 2024Q4: 88,000 shares; 2025Q1: 113,550 shares; 2025Q2: 135,550 shares; 2025Q3: 170,000 shares 170,000$1.24M0.22%+34,450Timeline
MRNAMODERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 40,482 shares; 2024Q4: 82,476 shares; 2025Q1: 75,576 shares; 2025Q2: 103,433 shares; 2025Q3: 47,000 shares 47,000$1.21M0.22%-56,433Timeline
SASEABRIDGE GOLD INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 32,087 shares; 2024Q4: 35,987 shares; 2025Q1: 44,074 shares; 2025Q2: 44,074 shares; 2025Q3: 48,474 shares 48,474$1.17M0.21%+4,400Timeline
PFEPFIZER INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 21,978 shares; 2024Q4: 21,978 shares; 2025Q1: 32,327 shares; 2025Q2: 37,029 shares; 2025Q3: 37,750 shares 37,750$962K0.17%+721Timeline
ALXOALX ONCOLOGY HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 509,059 shares; 2024Q4: 509,059 shares; 2025Q1: 509,059 shares; 2025Q2: 509,059 shares; 2025Q3: 509,059 shares 509,059$932K0.17%0Timeline
VZLAVIZSLA SILVER CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 116,521 shares; 2024Q4: 116,521 shares; 2025Q1: 192,487 shares; 2025Q2: 250,790 shares; 2025Q3: 204,654 shares 204,654$884K0.16%-46,136Timeline
NOVNOV INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 37,925 shares; 2024Q4: 42,889 shares; 2025Q1: 49,745 shares; 2025Q2: 63,876 shares; 2025Q3: 63,876 shares 63,876$846K0.15%0Timeline
PAASPAN AMERN SILVER CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 26,484 shares; 2024Q4: 21,284 shares; 2025Q1: 21,284 shares; 2025Q2: 29,747 shares; 2025Q3: 18,531 shares 18,531$718K0.13%-11,216Timeline
URNMSPROTT FDS TRQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 8,856 shares; 2024Q4: 10,276 shares; 2025Q1: 12,114 shares; 2025Q2: 16,278 shares; 2025Q3: 11,448 shares 11,448$692K0.12%-4,830Timeline
SLBSLB LIMITEDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 19,697 shares 19,697$677K0.12%newTimeline
RXRXRECURSION PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 78,000 shares; 2024Q4: 119,000 shares; 2025Q1: 119,000 shares; 2025Q2: 119,000 shares; 2025Q3: 119,000 shares 119,000$581K0.1%0Timeline
SDSANDRIDGE ENERGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 23,300 shares; 2024Q4: 23,300 shares; 2025Q1: 23,300 shares; 2025Q2: 37,022 shares; 2025Q3: 50,392 shares 50,392$568K0.1%+13,370Timeline
AUTLAUTOLUS THERAPEUTICS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 185,639 shares; 2024Q4: 231,674 shares; 2025Q1: 251,674 shares; 2025Q2: 294,142 shares; 2025Q3: 308,837 shares 308,837$503K0.09%+14,695Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 120,000 shares; 2024Q4: 134,900 shares; 2025Q1: 134,900 shares; 2025Q2: 134,900 shares; 2025Q3: 134,900 shares 134,900$441K0.08%0Timeline
FATEFATE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 50,000 shares; 2024Q4: 87,000 shares; 2025Q1: 109,026 shares; 2025Q2: 111,090 shares; 2025Q3: 333,219 shares 333,219$420K0.08%+222,129Timeline
VALVALARIS LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 7,611 shares; 2024Q4: 14,182 shares; 2025Q1: 20,222 shares; 2025Q2: 13,803 shares; 2025Q3: 8,315 shares 8,315$406K0.07%-5,488Timeline
NENOBLE CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 10,525 shares; 2024Q4: 10,525 shares; 2025Q1: 14,287 shares; 2025Q2: 14,287 shares; 2025Q3: 14,287 shares 14,287$404K0.07%0Timeline
RIGTRANSOCEAN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 102,000 shares 102,000$318K0.06%newTimeline
SBSWSIBANYE STILLWATER LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 34,040 shares; 2024Q4: 34,040 shares; 2025Q1: 34,040 shares; 2025Q2: 34,040 shares; 2025Q3: 26,232 shares 26,232$295K0.05%-7,808Timeline
TDWTIDEWATER INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: 5,350 shares; 2025Q3: 5,483 shares 5,483$292K0.05%+133Timeline
VYGRVOYAGER THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: not reported; 2024Q4: not reported; 2025Q1: 21,645 shares; 2025Q2: 25,241 shares; 2025Q3: 45,000 shares 45,000$210K0.04%+19,759Timeline

Sold out in Q3 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CVNACARVANA CO5,000$1.68Mshares
SRPTSAREPTA THERAPEUTICS INC39,400$698Kshares
EMX RTY CORPEMX RTY CORP216,968$545Kshares
DYNDYNE THERAPEUTICS INC27,566$239Kshares

How Q3 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001754960-25-000748 base2025-11-04acceptance time not in the bulk data set